What is Healthequity, Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Healthequity, Inc.'s reported free cash flow gives $139.81 per share. The share price was $88.25 on September 25, 2026, 37% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 7.5% | 10.0% | $83.65 | -5% |
| Base | 12.5% | 9.0% | $139.81 | +58% |
| Bull | 17.5% | 8.0% | $251.70 | +185% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $182.77 | $196.08 | $212.35 | $232.69 | $258.84 |
| 8.0% | $150.56 | $159.19 | $169.40 | $181.64 | $196.60 |
| 9.0% | $127.10 | $133.00 | $139.81 | $147.76 | $157.15 |
| 10.0% | $109.28 | $113.48 | $118.23 | $123.67 | $129.94 |
| 11.0% | $95.32 | $98.40 | $101.83 | $105.70 | $110.09 |
Where the presets come from
Base: years 1 to 5 grow at Healthequity, Inc.'s revenue growth rate over the last 5 fiscal years (12.4% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions